42 Chapter 2 32. Lanshoeft C, Cianferani S, Heudi O. Generic Hybrid Ligand Binding Assay Liquid Chromatography High-Resolution Mass Spectrometry-Based Workflow for Multiplexed Human Immunoglobulin G1 Quantification at the Intact Protein Level: Application to Preclinical Pharmacokinetic Studies. Anal Chem. 2017; 89: 2628-2635. 33. Lebert D, Picard G, Beau-Larvor C, Troncy L, Lacheny C, Maynadier B, Low W, Mouz N, Brun V, KlinguerHamour C, Jaquinod M, Beck A. Absolute and multiplex quantification of antibodies in serum using PSAQ standards and LC-MS/MS. Bioanalysis. 2015; 7: 1237-1251. 34. Xu K, Liu L, Maia M, Li J, Lowe J, Song A, Kaur S. A multiplexed hybrid LC-MS/MS pharmacokinetic assay to measure two co-administered monoclonal antibodies in a clinical study. Bioanalysis. 2014; 6: 1781-1794. 35. DeSilva B, Smith W, Weiner R, Kelley M, Smolec J, Lee B, Khan M, Tacey R, Hill H, Celniker A. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res. 2003; 20: 1885-1900. 36. European Medicines Agency. Guideline on bioanalytical method validation, 2011. https://www.ema. europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf. Accessed on 22-11-2017. 37. Vande Casteele N, Buurman DJ, Sturkenboom MG, Kleibeuker JH, Vermeire S, Rispens T, van der Kleij D, Gils A, Dijkstra G. Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays. Aliment Pharmacol Ther. 2012; 36: 765-771. 38. Willeman T, Jourdil JF, Gautier-Veyret E, Bonaz B, Stanke-Labesque F. A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn’s disease. Anal Chim Acta. 2019; 1067: 63-70. 39. Wacker C, Berger CN, Girard P, Meier R. Glycosylation profiles of therapeutic antibody pharmaceuticals. Eur J Pharm Biopharm. 2011; 79: 503-507. 40. Raju TS, Jordan RE. Galactosylation variations in marketed therapeutic antibodies. MAbs. 2012; 4: 385391. 41. Batra J, Rathore AS. Glycosylation of monoclonal antibody products: Current status and future prospects. Biotechnol Prog. 2016; 32: 1091-1102. 42. Damen CW, Derissen EJ, Schellens JH, Rosing H, Beijnen JH. The bioanalysis of the monoclonal antibody trastuzumab by high-performance liquid chromatography with fluorescence detection after immunoaffinity purification from human serum. J Pharm Biomed Anal. 2009; 50: 861-866. 43. Todoroki K, Nakano T, Eda Y, Ohyama K, Hayashi H, Tsuji D, Min JZ, Inoue K, Iwamoto N, Kawakami A, Ueki Y, Itoh K, Toyo’oka T. Bioanalysis of bevacizumab and infliximab by high-temperature reversed-phase liquid chromatography with fluorescence detection after immunoaffinity magnetic purification. Anal Chim Acta. 2016; 916: 112-119. 44. Mills JR, Cornec D, Dasari S, Ladwig PM, Hummel AM, Cheu M, Murray DL, Willrich MA, Snyder MR, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Specks U, Barnidge DR. Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis. Anal Chem. 2016; 88: 6317-6325. 45. Liu H, Manuilov AV, Chumsae C, Babineau ML, Tarcsa E. Quantitation of a recombinant monoclonal antibody in monkey serum by liquid chromatography-mass spectrometry. Anal Biochem. 2011; 414: 147-153.
RkJQdWJsaXNoZXIy MTk4NDMw